首页 > 最新文献

中国医师杂志最新文献

英文 中文
Progress in targeted therapy for high-risk diffuse large B cell lymphoma 高危弥漫性大B细胞淋巴瘤的靶向治疗进展
Q4 Medicine Pub Date : 2019-12-20 DOI: 10.3760/CMA.J.ISSN.1008-1372.2019.12.048
Jiaxun Guo
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of adult lymphoma and is a group of invasive and heterogeneous diseases. Although rituximab in combination with CHOP regimen (R-CHOP) for DLBCL is better, one third of patients have relapsed/refractory conditions. DLBCL is divided into many subtypes due to its high heterogeneity. Different histological types have different response to treatment. High-risk DLBCL has little effect on R-CHOP treatment. How to further improve the first-line cure rate of high-risk DLBCL has become an important challenge in the field of lymphoma treatment. Currently in the era of precision medicine, in recent years, many new targeted drugs, such as immunosuppressive agents, mammalian target of rapamycin (mTOR) receptor inhibitors and Bruton tyrosine kinase (BTK) inhibitors, have been developed for DLBCL-related pathways and molecular targets, provide more new possibilities for the treatment of DLBCL. Key words: Lymphoma, large B-cell, diffuse; Targeted therapy; Review
弥漫性大b细胞淋巴瘤(DLBCL)是成人淋巴瘤最常见的亚型,是一组侵袭性和异质性疾病。虽然利妥昔单抗联合CHOP方案(R-CHOP)治疗DLBCL更好,但三分之一的患者有复发/难治性疾病。DLBCL因其异质性高,可分为多个亚型。不同的组织学类型对治疗有不同的反应。高危大肝癌R-CHOP治疗效果不明显。如何进一步提高高危DLBCL的一线治愈率,已成为淋巴瘤治疗领域的重要挑战。目前在精准医疗时代,近年来针对DLBCL相关通路和分子靶点,开发出免疫抑制剂、哺乳动物雷帕霉素靶蛋白(mTOR)受体抑制剂、布鲁顿酪氨酸激酶(BTK)抑制剂等许多新的靶向药物,为DLBCL的治疗提供了更多新的可能。关键词:淋巴瘤,大b细胞,弥漫性;靶向治疗;审查
{"title":"Progress in targeted therapy for high-risk diffuse large B cell lymphoma","authors":"Jiaxun Guo","doi":"10.3760/CMA.J.ISSN.1008-1372.2019.12.048","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-1372.2019.12.048","url":null,"abstract":"Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of adult lymphoma and is a group of invasive and heterogeneous diseases. Although rituximab in combination with CHOP regimen (R-CHOP) for DLBCL is better, one third of patients have relapsed/refractory conditions. DLBCL is divided into many subtypes due to its high heterogeneity. Different histological types have different response to treatment. High-risk DLBCL has little effect on R-CHOP treatment. How to further improve the first-line cure rate of high-risk DLBCL has become an important challenge in the field of lymphoma treatment. Currently in the era of precision medicine, in recent years, many new targeted drugs, such as immunosuppressive agents, mammalian target of rapamycin (mTOR) receptor inhibitors and Bruton tyrosine kinase (BTK) inhibitors, have been developed for DLBCL-related pathways and molecular targets, provide more new possibilities for the treatment of DLBCL. \u0000 \u0000 \u0000Key words: \u0000Lymphoma, large B-cell, diffuse; Targeted therapy; Review","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75835474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The value of combined detection of serum CysC, urinary β2-MG, and L-FABP in early diagnosis of acute renal injury after cardiac surgery 血清CysC、尿β2-MG、L-FABP联合检测在心脏术后急性肾损伤早期诊断中的价值
Q4 Medicine Pub Date : 2019-12-20 DOI: 10.3760/CMA.J.ISSN.1008-1372.2019.12.015
Fang Liu, L. Xue
Objective To explore the value of combined detection of serum cystatin C (CysC), urinary β2-microglobulin (β2-MG), and liver type fatty acid binding protein (L-FABP) in early diagnosis of acute renal injury after cardiac surgery. Methods 126 patients undergoing cardiac surgery in our hospital from April 2015 to August 2016 were selected as the subjects, according to the occurrence of acute renal injury after operation, 48 cases were divided into acute renal injury (AKI) group and 78 cases into non-acute renal injury (non AKI) group, the levels of serum CysC, urine β2-MG, and L-FABP were detected in the two groups. Receiver operating characteristic (ROC) curve was used to analyze the effects of serum CysC, urine β2-MG, L-FABP in the early diagnosis of acute renal injury after cardiac surgery. Results The incidence of AKI after cardiac surgery was 38.10% (48/126); the serum CysC level in group AKI was significantly higher than that in non AKI group (P<0.05); the levels of urine β2-MG and L-FABP were significantly higher than those in non AKI group (P<0.05); the area under curve (AUC) of serum CysC for AKI diagnosis after cardiac surgery was 0.874 (P<0.05), with diagnostic sensitivity 85.7%, and specificity 76.5%; the AUC area of urinary β2-MG for AKI diagnosis after cardiac surgery was 0.754 (P<0.05), with diagnostic sensitivity 92.9%, and specificity 73.5%, respectively; the AUC area of urinary L-FABP for AKI diagnosis after cardiac surgery was 0.834 (P<0.05), with diagnostic sensitivity 92.9%, and specificity 74.1%. The AUC area of combined diagnosis of the three was 0.914 (P<0.05), with the diagnostic sensitivity 92.1%, and specificity 82.4%. Conclusions Serum Cys C, urine β 2-MG and L-FABP levels were significantly increased in patients with AKI. The diagnosis of the three alone has a certain reference value, which is lower than the combined diagnosis. The combined diagnosis of the three can provide an important reference for screening acute renal injury after heart surgery. Key words: Cardiac surgical procedures; Postoperative complications; Acute kidney injury; Cystatin C; beta 2-microglobulin; Liver type fatty acid-binding protein
目的探讨联合检测血清胱抑素C (CysC)、尿β2-微球蛋白(β2-MG)、肝型脂肪酸结合蛋白(L-FABP)在心脏术后急性肾损伤早期诊断中的价值。方法选取2015年4月~ 2016年8月在我院行心脏外科手术的患者126例,根据术后急性肾损伤的发生情况,将48例分为急性肾损伤组(AKI), 78例分为非急性肾损伤组(非AKI),检测两组患者血清CysC、尿β2-MG、L-FABP水平。采用受试者工作特征(ROC)曲线分析血清CysC、尿β2-MG、L-FABP在心脏手术后急性肾损伤早期诊断中的作用。结果心脏手术后AKI发生率为38.10% (48/126);AKI组血清CysC水平显著高于非AKI组(P<0.05);尿β2-MG、L-FABP水平显著高于非AKI组(P<0.05);血清CysC曲线下面积(AUC)诊断心脏术后AKI为0.874 (P<0.05),诊断敏感性85.7%,特异性76.5%;尿β2-MG对心脏术后AKI诊断的AUC面积为0.754 (P<0.05),诊断敏感性92.9%,特异性73.5%;尿L-FABP诊断心脏术后AKI的AUC面积为0.834 (P<0.05),诊断敏感性92.9%,特异性74.1%。三者联合诊断的AUC面积为0.914 (P<0.05),诊断敏感性92.1%,特异性82.4%。结论AKI患者血清Cys C、尿β 2-MG、L-FABP水平显著升高。三者单独诊断具有一定的参考价值,低于联合诊断。三者联合诊断可为心脏手术后急性肾损伤筛查提供重要参考。关键词:心脏外科手术;术后并发症;急性肾损伤;半胱氨酸蛋白酶抑制物C;β2-microglobulin;肝型脂肪酸结合蛋白
{"title":"The value of combined detection of serum CysC, urinary β2-MG, and L-FABP in early diagnosis of acute renal injury after cardiac surgery","authors":"Fang Liu, L. Xue","doi":"10.3760/CMA.J.ISSN.1008-1372.2019.12.015","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-1372.2019.12.015","url":null,"abstract":"Objective \u0000To explore the value of combined detection of serum cystatin C (CysC), urinary β2-microglobulin (β2-MG), and liver type fatty acid binding protein (L-FABP) in early diagnosis of acute renal injury after cardiac surgery. \u0000 \u0000 \u0000Methods \u0000126 patients undergoing cardiac surgery in our hospital from April 2015 to August 2016 were selected as the subjects, according to the occurrence of acute renal injury after operation, 48 cases were divided into acute renal injury (AKI) group and 78 cases into non-acute renal injury (non AKI) group, the levels of serum CysC, urine β2-MG, and L-FABP were detected in the two groups. Receiver operating characteristic (ROC) curve was used to analyze the effects of serum CysC, urine β2-MG, L-FABP in the early diagnosis of acute renal injury after cardiac surgery. \u0000 \u0000 \u0000Results \u0000The incidence of AKI after cardiac surgery was 38.10% (48/126); the serum CysC level in group AKI was significantly higher than that in non AKI group (P<0.05); the levels of urine β2-MG and L-FABP were significantly higher than those in non AKI group (P<0.05); the area under curve (AUC) of serum CysC for AKI diagnosis after cardiac surgery was 0.874 (P<0.05), with diagnostic sensitivity 85.7%, and specificity 76.5%; the AUC area of urinary β2-MG for AKI diagnosis after cardiac surgery was 0.754 (P<0.05), with diagnostic sensitivity 92.9%, and specificity 73.5%, respectively; the AUC area of urinary L-FABP for AKI diagnosis after cardiac surgery was 0.834 (P<0.05), with diagnostic sensitivity 92.9%, and specificity 74.1%. The AUC area of combined diagnosis of the three was 0.914 (P<0.05), with the diagnostic sensitivity 92.1%, and specificity 82.4%. \u0000 \u0000 \u0000Conclusions \u0000Serum Cys C, urine β 2-MG and L-FABP levels were significantly increased in patients with AKI. The diagnosis of the three alone has a certain reference value, which is lower than the combined diagnosis. The combined diagnosis of the three can provide an important reference for screening acute renal injury after heart surgery. \u0000 \u0000 \u0000Key words: \u0000Cardiac surgical procedures; Postoperative complications; Acute kidney injury; Cystatin C; beta 2-microglobulin; Liver type fatty acid-binding protein","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77093527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benefits and risks of intravenous thrombolysis in minor stroke and effects of combined urinary kallidinogenase on long-term prognosis of stroke 静脉溶栓治疗轻度脑卒中的益处和风险及联合尿碱二酚酶对脑卒中长期预后的影响
Q4 Medicine Pub Date : 2019-12-20 DOI: 10.3760/CMA.J.ISSN.1008-1372.2019.12.010
Qiang Zhou, P. Lin, L. Chi, Jing Lin, W. Chi
Objective To explore the clinical benefits and risks of intravenous thrombolysis combined with urinary kallidinogenase in the treatment of minor stroke. Methods The clinical data of 86 patients with minor stroke were retrospectively analyzed. Patients who received intravenous thrombolysis combined with urinary kallidinogenase were included in observation group (n=48), and those who received intravenous thrombolysis alone were included in control group (n=38). Before treatment and after 2 weeks of treatment, the imaging blood flow perfusion parameters [cerebral blood flow (CBF), mean transit time (MTT), time to peak (TTP)], and breath holding test indexes [cerebral vascular reactivity (CVR), breath holding index (BHI)] and serum biochemical indicators [vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF)] were compared between the two groups. The occurrence of adverse drug reactions during course of treatment and rehabilitation effects at 3 months after treatment [US National Institutes of Health Stroke Scale (NIHSS), modified Rankin Scale (mRS)] were analyzed in the two groups. Results After 2 weeks of treatment, the CBF, CVR, BHI and serum levels of VEGF and bFGF in the two groups were significantly higher than those before treatment, and the indexes in observation group were significantly higher than those in control group (P 0.05). At 3 months after treatment, there was no statistically significant difference in the effective rate of rehabilitation between the two groups (P>0.05), but the Mann-Whitney U rank sum test between-groups showed that the overall rehabilitation effects in observation group were significantly better than those in control group (P<0.05). Conclusions Intravenous thrombolysis has certain treatment effects in patients with minor stroke, and its safety is within the clinical controllable range. Combined with urinary kallidinogenase can obtain ideal long-term prognosis, and it is beneficial to the recovery of neurological function. Key words: Stroke; Thrombolytic therapy; Urinary kallidinogenase; Prognosis
目的探讨静脉溶栓联合尿碱二酚酶治疗轻度脑卒中的临床获益及风险。方法回顾性分析86例轻度脑卒中患者的临床资料。观察组48例为静脉溶栓联合尿碱二酚原酶组,对照组38例为单独静脉溶栓组。比较两组患者治疗前和治疗2周后血流灌注成像参数[脑血流量(CBF)、平均传递时间(MTT)、到达峰值时间(TTP)]、屏气试验指标[脑血管反应性(CVR)、屏气指数(BHI)]和血清生化指标[血管内皮生长因子(VEGF)、碱性成纤维细胞生长因子(bFGF)]。分析两组患者治疗过程中药物不良反应发生情况及治疗后3个月的康复效果[美国国立卫生研究院卒中量表(NIHSS)、改良Rankin量表(mRS)]。结果治疗2周后,两组患者CBF、CVR、BHI及血清VEGF、bFGF水平均显著高于同组治疗前,且观察组各指标均显著高于对照组(P < 0.05)。治疗后3个月,两组患者康复有效率比较,差异无统计学意义(P>0.05),但组间Mann-Whitney U秩和检验显示,观察组患者整体康复效果显著优于对照组(P<0.05)。结论静脉溶栓对轻度脑卒中患者有一定的治疗效果,其安全性在临床可控范围内。联合尿碱二酚原酶治疗可获得理想的远期预后,并有利于神经功能的恢复。关键词:卒中;溶栓治疗;尿血管舒缓素;预后
{"title":"Benefits and risks of intravenous thrombolysis in minor stroke and effects of combined urinary kallidinogenase on long-term prognosis of stroke","authors":"Qiang Zhou, P. Lin, L. Chi, Jing Lin, W. Chi","doi":"10.3760/CMA.J.ISSN.1008-1372.2019.12.010","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-1372.2019.12.010","url":null,"abstract":"Objective \u0000To explore the clinical benefits and risks of intravenous thrombolysis combined with urinary kallidinogenase in the treatment of minor stroke. \u0000 \u0000 \u0000Methods \u0000The clinical data of 86 patients with minor stroke were retrospectively analyzed. Patients who received intravenous thrombolysis combined with urinary kallidinogenase were included in observation group (n=48), and those who received intravenous thrombolysis alone were included in control group (n=38). Before treatment and after 2 weeks of treatment, the imaging blood flow perfusion parameters [cerebral blood flow (CBF), mean transit time (MTT), time to peak (TTP)], and breath holding test indexes [cerebral vascular reactivity (CVR), breath holding index (BHI)] and serum biochemical indicators [vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF)] were compared between the two groups. The occurrence of adverse drug reactions during course of treatment and rehabilitation effects at 3 months after treatment [US National Institutes of Health Stroke Scale (NIHSS), modified Rankin Scale (mRS)] were analyzed in the two groups. \u0000 \u0000 \u0000Results \u0000After 2 weeks of treatment, the CBF, CVR, BHI and serum levels of VEGF and bFGF in the two groups were significantly higher than those before treatment, and the indexes in observation group were significantly higher than those in control group (P 0.05). At 3 months after treatment, there was no statistically significant difference in the effective rate of rehabilitation between the two groups (P>0.05), but the Mann-Whitney U rank sum test between-groups showed that the overall rehabilitation effects in observation group were significantly better than those in control group (P<0.05). \u0000 \u0000 \u0000Conclusions \u0000Intravenous thrombolysis has certain treatment effects in patients with minor stroke, and its safety is within the clinical controllable range. Combined with urinary kallidinogenase can obtain ideal long-term prognosis, and it is beneficial to the recovery of neurological function. \u0000 \u0000 \u0000Key words: \u0000Stroke; Thrombolytic therapy; Urinary kallidinogenase; Prognosis","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79494765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of inflammatory stimulation on biological function of human umbilical cord mesenchymal stem cells and its mechanism 炎症刺激对人脐带间充质干细胞生物学功能的影响及其机制
Q4 Medicine Pub Date : 2019-12-20 DOI: 10.3760/CMA.J.ISSN.1008-1372.2019.12.017
Ye Wang, Junling Li, Shan Ji, Wei Wang, Yan Li
Objective To investigate the effect of inflammatory stimulation on the biological function of human umbilical cord mesenchymal stem cells (MSCs) and its mechanism. Methods Under sterile condition, 40-60 ml cord blood of normal full-term caesarean section was taken, and the cells were separated by Ficoll Hypaque gradient centrifugation. After 24 hours of conventional culture, the cells were divided into 4 groups: C group (control group), LPSL group, LPSM group and LPSH group. Group C was added with complete culture medium. Group LPSL, group LPSM and group LPSH were added with equal amount of culture medium containing 12.5, 25, 50 μg/ml lipopolysaccharides (LPS) respectively. The effects of different concentrations of LPS on the proliferation and osteogenic differentiation of mesenchymal stem cells were observed. Results After incubation for 24 and 48 hours, the proliferation activity of MSCs in LPSL, LPSM and LPSH groups was higher than that in group C (P<0.05), and the proliferation ability of MSCs induced by low dose LPS for 48 h was the strongest (P<0.05). With the increase of culture time, the expression of nuclear factor kappa B (NF-κB) and Toll-like receptor 4 (TLR4) protein in the four groups increased gradually. The expression of NF-κB and TLR4 protein in the LPSL, LPSM and LPSH groups were higher than that in the control group (P<0.05). With the increase of LPS concentration, the expression of NF-κB and TLR4 protein increased gradually, with statistically significant difference (P<0.05). Alkaline phosphatase (ALP) activity and calcium nodule number in LPSL, LPSM and LPSH group were higher than those in group C; ALP activity and calcium nodule number in LPSM group were higher than those in LPSH group; ALP activity and calcium nodule number in LPSL group were higher than those in LPSM and LPSH, group with statistically significant difference (P<0.05). Conclusions Inflammatory response can stimulate the proliferation and osteogenic differentiation of human umbilical cord mesenchymal stem cells. Low concentration of LPS may be an ideal factor for the osteogenic differentiation of umbilical cord mesenchymal stem cells. It has certain significance and application prospect in the actual clinical disease treatment, but the detailed mechanism of action and whether the effect of lower dose is better still to be further studied. Key words: Lipopolysaccharides; Umbilical cord; Mesenchymal stromal cells; Cell proliferation; In vitro
目的探讨炎症刺激对人脐带间充质干细胞(MSCs)生物学功能的影响及其机制。方法在无菌条件下取正常足月剖宫产患者脐带血40 ~ 60 ml,采用Ficoll Hypaque梯度离心分离细胞。常规培养24h后,将细胞分为4组:C组(对照组)、LPSL组、LPSM组、LPSH组。C组添加完整培养基。LPSL组、LPSM组和LPSH组分别加入等量含有12.5、25、50 μg/ml脂多糖(LPS)的培养基。观察不同浓度LPS对间充质干细胞增殖和成骨分化的影响。结果LPSL、LPSM和LPSH组MSCs孵育24、48 h后的增殖活性均高于C组(P<0.05),且低剂量LPS诱导48 h后MSCs的增殖能力最强(P<0.05)。随着培养时间的延长,4组细胞核因子κB (NF-κB)和toll样受体4 (TLR4)蛋白的表达均逐渐升高。LPSL、LPSM、LPSH组NF-κB、TLR4蛋白表达均高于对照组(P<0.05)。随着LPS浓度的升高,NF-κB、TLR4蛋白表达逐渐升高,差异有统计学意义(P<0.05)。LPSL、LPSM和LPSH组碱性磷酸酶(ALP)活性和钙结节数均高于C组;LPSM组ALP活性和钙结节数高于LPSH组;LPSL组ALP活性、钙结节数均高于LPSM、LPSH组,差异有统计学意义(P<0.05)。结论炎症反应可促进人脐带间充质干细胞的增殖和成骨分化。低浓度的脂多糖可能是脐带间充质干细胞成骨分化的理想因子。在实际临床疾病治疗中具有一定的意义和应用前景,但具体的作用机制以及是否低剂量效果更好还有待进一步研究。关键词:脂多糖;脐带;间质间质细胞;细胞增殖;在体外
{"title":"Effect of inflammatory stimulation on biological function of human umbilical cord mesenchymal stem cells and its mechanism","authors":"Ye Wang, Junling Li, Shan Ji, Wei Wang, Yan Li","doi":"10.3760/CMA.J.ISSN.1008-1372.2019.12.017","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-1372.2019.12.017","url":null,"abstract":"Objective \u0000To investigate the effect of inflammatory stimulation on the biological function of human umbilical cord mesenchymal stem cells (MSCs) and its mechanism. \u0000 \u0000 \u0000Methods \u0000Under sterile condition, 40-60 ml cord blood of normal full-term caesarean section was taken, and the cells were separated by Ficoll Hypaque gradient centrifugation. After 24 hours of conventional culture, the cells were divided into 4 groups: C group (control group), LPSL group, LPSM group and LPSH group. Group C was added with complete culture medium. Group LPSL, group LPSM and group LPSH were added with equal amount of culture medium containing 12.5, 25, 50 μg/ml lipopolysaccharides (LPS) respectively. The effects of different concentrations of LPS on the proliferation and osteogenic differentiation of mesenchymal stem cells were observed. \u0000 \u0000 \u0000Results \u0000After incubation for 24 and 48 hours, the proliferation activity of MSCs in LPSL, LPSM and LPSH groups was higher than that in group C (P<0.05), and the proliferation ability of MSCs induced by low dose LPS for 48 h was the strongest (P<0.05). With the increase of culture time, the expression of nuclear factor kappa B (NF-κB) and Toll-like receptor 4 (TLR4) protein in the four groups increased gradually. The expression of NF-κB and TLR4 protein in the LPSL, LPSM and LPSH groups were higher than that in the control group (P<0.05). With the increase of LPS concentration, the expression of NF-κB and TLR4 protein increased gradually, with statistically significant difference (P<0.05). Alkaline phosphatase (ALP) activity and calcium nodule number in LPSL, LPSM and LPSH group were higher than those in group C; ALP activity and calcium nodule number in LPSM group were higher than those in LPSH group; ALP activity and calcium nodule number in LPSL group were higher than those in LPSM and LPSH, group with statistically significant difference (P<0.05). \u0000 \u0000 \u0000Conclusions \u0000Inflammatory response can stimulate the proliferation and osteogenic differentiation of human umbilical cord mesenchymal stem cells. Low concentration of LPS may be an ideal factor for the osteogenic differentiation of umbilical cord mesenchymal stem cells. It has certain significance and application prospect in the actual clinical disease treatment, but the detailed mechanism of action and whether the effect of lower dose is better still to be further studied. \u0000 \u0000 \u0000Key words: \u0000Lipopolysaccharides; Umbilical cord; Mesenchymal stromal cells; Cell proliferation; In vitro","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81711166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of different doses of low molecular weight heparin on coagulation mechanism in thoracic cancer surgery 不同剂量低分子肝素对胸部肿瘤手术凝血机制的影响
Q4 Medicine Pub Date : 2019-12-20 DOI: 10.3760/CMA.J.ISSN.1008-1372.2019.12.007
P. Zhou, Yaqian Wang, Bingqing Li, Xiaowei Chen, Yi Jin, Zhanlin Guo
Objective To study the effect of different doses of low molecular weight heparin on coagulation mechanism after thoracic surgery. Methods A prospective randomized controlled study was conducted to select patients who underwent thoracic cancer surgery (lung cancer, esophageal cancer, cardiac cancer) from February 2015 to October 2018. According to the Caprini risk assessment model, 101 patients with high risk of deep venous thrombosis were randomly assigned to groups A, B and C. Control group A (34 cases) did not use low molecular weight heparin; group B (34 cases) used prophylactic low molecular weight heparin calcium after operation; group C (33 cases) used therapeutic low molecular weight heparin calcium after operation. The platelet count (PLT), fibrinogen (FIB), prothrombin time (PT), D-dimer (D-D), postoperative thoracic drainage and lower extremity deep vein ultrasound were observed before and after operation. Results The incidence of deep venous thrombosis (DVT) was 11.76% in group A, 2.94% in group B and 3.03% in group C, with significant difference between group B and C and group A (P 0.05). The levels of FIB and D-D after operation were significantly higher than those before operation (P<0.05), but the levels of indexes in group B and C were significantly lower than those in group A (P<0.05). Conclusions Low molecular weight heparin calcium does not increase bleeding and thoracic drainage, which is beneficial to improve the hypercoagulable state of patients and has good safety. However, the use of low molecular weight heparin calcium in different doses (prevention amount and treatment amount) has no significant effect on the occurrence of lower extremity deep vein thrombosis and coagulation index. Key words: Thoracic neoplasms; Thoracic surgical procedures; Heparin, low-molecular-weight; Blood coagulation tests
目的探讨不同剂量低分子肝素对胸外科术后凝血机制的影响。方法采用前瞻性随机对照研究,选取2015年2月至2018年10月接受胸部肿瘤手术(肺癌、食管癌、贲门癌)的患者。根据capriini风险评估模型,101例深静脉血栓形成高危患者随机分为A、B、c组,对照组(34例)不使用低分子肝素;B组(34例)术后预防性应用低分子肝素钙;C组(33例)术后应用低分子肝素钙治疗。观察手术前后血小板计数(PLT)、纤维蛋白原(FIB)、凝血酶原时间(PT)、d -二聚体(D-D)、术后胸腔引流及下肢深静脉超声。结果A组深静脉血栓(DVT)发生率为11.76%,B组为2.94%,C组为3.03%,B、C组与A组比较差异有统计学意义(P < 0.05)。术后FIB、D-D水平均显著高于术前(P<0.05),但B、C组各项指标均显著低于A组(P<0.05)。结论低分子量肝素钙不增加出血和胸腔引流,有利于改善患者高凝状态,安全性好。而使用低分子肝素钙不同剂量(预防量和治疗量)对下肢深静脉血栓形成及凝血指数的发生无显著影响。关键词:胸部肿瘤;胸外科手术;肝素、低分子量;凝血试验
{"title":"Effect of different doses of low molecular weight heparin on coagulation mechanism in thoracic cancer surgery","authors":"P. Zhou, Yaqian Wang, Bingqing Li, Xiaowei Chen, Yi Jin, Zhanlin Guo","doi":"10.3760/CMA.J.ISSN.1008-1372.2019.12.007","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-1372.2019.12.007","url":null,"abstract":"Objective \u0000To study the effect of different doses of low molecular weight heparin on coagulation mechanism after thoracic surgery. \u0000 \u0000 \u0000Methods \u0000A prospective randomized controlled study was conducted to select patients who underwent thoracic cancer surgery (lung cancer, esophageal cancer, cardiac cancer) from February 2015 to October 2018. According to the Caprini risk assessment model, 101 patients with high risk of deep venous thrombosis were randomly assigned to groups A, B and C. Control group A (34 cases) did not use low molecular weight heparin; group B (34 cases) used prophylactic low molecular weight heparin calcium after operation; group C (33 cases) used therapeutic low molecular weight heparin calcium after operation. The platelet count (PLT), fibrinogen (FIB), prothrombin time (PT), D-dimer (D-D), postoperative thoracic drainage and lower extremity deep vein ultrasound were observed before and after operation. \u0000 \u0000 \u0000Results \u0000The incidence of deep venous thrombosis (DVT) was 11.76% in group A, 2.94% in group B and 3.03% in group C, with significant difference between group B and C and group A (P 0.05). The levels of FIB and D-D after operation were significantly higher than those before operation (P<0.05), but the levels of indexes in group B and C were significantly lower than those in group A (P<0.05). \u0000 \u0000 \u0000Conclusions \u0000Low molecular weight heparin calcium does not increase bleeding and thoracic drainage, which is beneficial to improve the hypercoagulable state of patients and has good safety. However, the use of low molecular weight heparin calcium in different doses (prevention amount and treatment amount) has no significant effect on the occurrence of lower extremity deep vein thrombosis and coagulation index. \u0000 \u0000 \u0000Key words: \u0000Thoracic neoplasms; Thoracic surgical procedures; Heparin, low-molecular-weight; Blood coagulation tests","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88616034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Warfarin individualized medication in the treatment of first acute deep venous thrombosis of lower extremity 华法林个体化治疗首次急性下肢深静脉血栓的疗效观察
Q4 Medicine Pub Date : 2019-12-20 DOI: 10.3760/CMA.J.ISSN.1008-1372.2019.12.003
B. Yan, Yongquan Gu, Ziqiang Sun, Chunmei Wang, Chengchao Zhang
Objective To study the effect of warfarin individualized drug regimen based on gene detection on anticoagulation in patients with acute deep vein thrombosis (DVT). Methods From January 2016 to June 2017, 62 patients with DVT diagnosed for the first time in vascular surgery of the Affiliated Hospital of Jining Medical College were analyzed retrospectively, including 33 in the individualized group and 29 in the experience group. All patients were diagnosed by Color Doppler Ultrasound (CDUS). Gender, age, the results of the initial international standardized ratio (INR) measurement, the time from the first dose to the INR standard, and whether the INR exceeds the standard in the process of increasing the dose were collected. Results There was no significant difference in sex, age and initial INR between the two groups (P>0.05). The time of reaching the standard in the individualized group was significantly lower than that in the experience group [(13.8±6.8)d vs (17.6±7.5)d, P<0.05]; There was no significant difference in INR between the two groups (P=0.377). Conclusions For the patients with DVT for the first time, the individualized drug regimen of warfarin based on the guidance of gene detection can shorten the time of reaching the standard without increasing the risk of bleeding. Key words: Warfarin; Genetic testing; Lower extremity deep vein thrombosis; International normalized ratio
目的探讨基于基因检测的华法林个体化用药方案对急性深静脉血栓患者抗凝治疗的影响。方法回顾性分析2016年1月至2017年6月济宁医学院附属医院血管外科首次诊断的DVT患者62例,其中个体化组33例,经验组29例。所有患者均采用彩色多普勒超声(CDUS)诊断。收集性别、年龄、初次国际标准化比率(INR)测量结果、从第一次剂量到INR标准的时间、在增加剂量过程中INR是否超标。结果两组患者性别、年龄、初始INR差异无统计学意义(P>0.05)。个体化治疗组达到标准的时间明显低于经验治疗组[(13.8±6.8)d vs(17.6±7.5)d, P<0.05];两组间INR差异无统计学意义(P=0.377)。结论对于首次DVT患者,以基因检测为指导的华法林个体化用药方案可在不增加出血风险的情况下缩短达标时间。关键词:华法林;基因检测;下肢深静脉血栓;国际标准化比率
{"title":"Warfarin individualized medication in the treatment of first acute deep venous thrombosis of lower extremity","authors":"B. Yan, Yongquan Gu, Ziqiang Sun, Chunmei Wang, Chengchao Zhang","doi":"10.3760/CMA.J.ISSN.1008-1372.2019.12.003","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-1372.2019.12.003","url":null,"abstract":"Objective \u0000To study the effect of warfarin individualized drug regimen based on gene detection on anticoagulation in patients with acute deep vein thrombosis (DVT). \u0000 \u0000 \u0000Methods \u0000From January 2016 to June 2017, 62 patients with DVT diagnosed for the first time in vascular surgery of the Affiliated Hospital of Jining Medical College were analyzed retrospectively, including 33 in the individualized group and 29 in the experience group. All patients were diagnosed by Color Doppler Ultrasound (CDUS). Gender, age, the results of the initial international standardized ratio (INR) measurement, the time from the first dose to the INR standard, and whether the INR exceeds the standard in the process of increasing the dose were collected. \u0000 \u0000 \u0000Results \u0000There was no significant difference in sex, age and initial INR between the two groups (P>0.05). The time of reaching the standard in the individualized group was significantly lower than that in the experience group [(13.8±6.8)d vs (17.6±7.5)d, P<0.05]; There was no significant difference in INR between the two groups (P=0.377). \u0000 \u0000 \u0000Conclusions \u0000For the patients with DVT for the first time, the individualized drug regimen of warfarin based on the guidance of gene detection can shorten the time of reaching the standard without increasing the risk of bleeding. \u0000 \u0000 \u0000Key words: \u0000Warfarin; Genetic testing; Lower extremity deep vein thrombosis; International normalized ratio","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80959398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of severe iliac artery stenosis treated by stenting without contrast agent 无造影剂支架置入治疗严重髂动脉狭窄1例
Q4 Medicine Pub Date : 2019-12-20 DOI: 10.3760/CMA.J.ISSN.1008-1372.2019.12.004
Z. Tong, Yongquan Gu, Lianrui Guo, Yang Li, Liqiang Li, Fei Wang, Jian Zhang
Re-use of contrast agent during endovascular treatment in patients with contrast agent allergy may lead to severe allergic reaction. For patients with localized stenosis of external iliac artery, endovascular therapy (stenting) is the first choice. Whether patients with severe iliac artery stenosis with contrast allergy can be treated with endovascular therapy is unknowed. A case of iliac artery stenting without contrast agent is reported in this paper. The successful implementation of this operation requires adequate preoperative and intraoperative preparation, and the accurate determination of the stenosis site and the presence or absence of residual stenosis during the operation. Key words: Angioplasty; Contrast media; Self expandable metallic stents; Iliac artery stenosis
造影剂过敏患者在血管内治疗时再次使用造影剂可能导致严重的过敏反应。对于局限性髂外动脉狭窄的患者,血管内治疗(支架置入术)是首选。严重髂动脉狭窄合并对比剂过敏患者是否可以血管内治疗尚不清楚。本文报道1例髂动脉支架置入不使用造影剂。该手术的成功实施需要充分的术前和术中准备,术中准确判断狭窄部位和有无残留狭窄。关键词:血管成形术;对比媒体;自膨胀金属支架;髂动脉狭窄
{"title":"A case of severe iliac artery stenosis treated by stenting without contrast agent","authors":"Z. Tong, Yongquan Gu, Lianrui Guo, Yang Li, Liqiang Li, Fei Wang, Jian Zhang","doi":"10.3760/CMA.J.ISSN.1008-1372.2019.12.004","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-1372.2019.12.004","url":null,"abstract":"Re-use of contrast agent during endovascular treatment in patients with contrast agent allergy may lead to severe allergic reaction. For patients with localized stenosis of external iliac artery, endovascular therapy (stenting) is the first choice. Whether patients with severe iliac artery stenosis with contrast allergy can be treated with endovascular therapy is unknowed. A case of iliac artery stenting without contrast agent is reported in this paper. The successful implementation of this operation requires adequate preoperative and intraoperative preparation, and the accurate determination of the stenosis site and the presence or absence of residual stenosis during the operation. \u0000 \u0000 \u0000Key words: \u0000Angioplasty; Contrast media; Self expandable metallic stents; Iliac artery stenosis","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89537140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis on risk factors for multidrug-resistant bacterial infections in patients in neurosurgical intensive care unit 神经外科重症监护病房患者多重耐药细菌感染危险因素分析
Q4 Medicine Pub Date : 2019-12-20 DOI: 10.3760/CMA.J.ISSN.1008-1372.2019.12.020
Yanlin Su, Liping Xu
Objective To analyze the risk factors of multidrug-resistant bacteria (MDRO) infection in patients in Neurosurgical intensive care unit (NSICU), and to provide reference for clinical prevention and treatment. Methods 1 251 patients with NSICU in our hospital from January 2012 to March 2018 were selected as the study subjects. The bacterial specimens were extracted. 380 patients with MDRO infection were the observation group, and 871 patients with non-MDRO infection in NSICU were the control group. The patients' medical records and clinical information were retrospectively analyzed, and multivariate logistic regression analysis was used to analyze the risk factors of MDRO infection in NSICU patients. Results There was no significant difference in the gender, age and body mass index (BMI) between the observation group and the control group (P>0.05). There was statistical significance in the proportion of hospitalization time, operation, use of urethra tube, mechanical ventilation, serious basic diseases and rational use of antibiotics between the observation group and the control group (P<0.05). According to the analysis on proportion of colony samples, the highest proportion in the observation group was sputum samples, accounted for 45.00%, followed by urine samples (21.58%), and the lowest proportion was other types of samples, accounted for 1.84%. The results of MDRO test showed that the highest proportion of pathogens was methicillin-resistant staphylococcus aureus (MRSA), accounted for 33.69%, followed by pseudomonas aeruginosa (PA), carbapenem-resistant acinetobacter baumannii (CR-AB), and the lowest proportion was stenotrophomonas maltophilia (SM), accounted for 1.58%. Logistic regression analysis showed that surgery, catheterization, mechanical ventilation, serious basic diseases and abuse of antibiotics were risk factors for MDRO infection in NSICU patients (P<0.05). Conclusions Invasive manipulation and antimicrobial abuse are the main risk factors for MDRO infection in NSICU patients, among which respiratory tract infection is the most serious and MRSA strain infection is the most common. The management of drugs and therapeutic devices should be scientific, rational and standardized in order to reduce the infection rate of MDRO. Key words: Intensive care units; Neurosurgery; Drug resistance, multiple, bacterial; Factor analysis, statistical
目的分析神经外科重症监护病房(NSICU)患者多重耐药菌(MDRO)感染的危险因素,为临床预防和治疗提供参考。方法选取2012年1月~ 2018年3月我院收治的NSICU患者1 251例作为研究对象。提取细菌标本。观察组380例MDRO感染,对照组871例NSICU非MDRO感染。回顾性分析患者病历及临床资料,采用多因素logistic回归分析NSICU患者MDRO感染的危险因素。结果观察组患者性别、年龄、体重指数(BMI)与对照组比较,差异均无统计学意义(P>0.05)。观察组患者住院时间、手术次数、使用尿道管、机械通气、严重基础疾病、合理使用抗生素的比例与对照组比较,差异均有统计学意义(P<0.05)。根据菌落样本比例分析,观察组中痰样本比例最高,占45.00%,其次是尿液样本(21.58%),其他类型样本比例最低,占1.84%。MDRO检测结果显示,病原菌比例最高的是耐甲氧西林金黄色葡萄球菌(MRSA),占33.69%,其次是铜绿假单胞菌(PA)、耐碳青霉烯不动杆菌鲍曼不动杆菌(CR-AB),比例最低的是嗜麦芽寡养单胞菌(SM),占1.58%。Logistic回归分析显示,手术、置管、机械通气、严重基础疾病和滥用抗生素是NSICU患者MDRO感染的危险因素(P<0.05)。结论侵入性操作和抗菌药物滥用是NSICU患者MDRO感染的主要危险因素,其中呼吸道感染最为严重,MRSA菌株感染最为常见。应科学、合理、规范地管理药品和医疗器械,以降低MDRO的感染率。关键词:重症监护病房;神经外科;耐药,多重,细菌;因子分析、统计学
{"title":"Analysis on risk factors for multidrug-resistant bacterial infections in patients in neurosurgical intensive care unit","authors":"Yanlin Su, Liping Xu","doi":"10.3760/CMA.J.ISSN.1008-1372.2019.12.020","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-1372.2019.12.020","url":null,"abstract":"Objective \u0000To analyze the risk factors of multidrug-resistant bacteria (MDRO) infection in patients in Neurosurgical intensive care unit (NSICU), and to provide reference for clinical prevention and treatment. \u0000 \u0000 \u0000Methods \u00001 251 patients with NSICU in our hospital from January 2012 to March 2018 were selected as the study subjects. The bacterial specimens were extracted. 380 patients with MDRO infection were the observation group, and 871 patients with non-MDRO infection in NSICU were the control group. The patients' medical records and clinical information were retrospectively analyzed, and multivariate logistic regression analysis was used to analyze the risk factors of MDRO infection in NSICU patients. \u0000 \u0000 \u0000Results \u0000There was no significant difference in the gender, age and body mass index (BMI) between the observation group and the control group (P>0.05). There was statistical significance in the proportion of hospitalization time, operation, use of urethra tube, mechanical ventilation, serious basic diseases and rational use of antibiotics between the observation group and the control group (P<0.05). According to the analysis on proportion of colony samples, the highest proportion in the observation group was sputum samples, accounted for 45.00%, followed by urine samples (21.58%), and the lowest proportion was other types of samples, accounted for 1.84%. The results of MDRO test showed that the highest proportion of pathogens was methicillin-resistant staphylococcus aureus (MRSA), accounted for 33.69%, followed by pseudomonas aeruginosa (PA), carbapenem-resistant acinetobacter baumannii (CR-AB), and the lowest proportion was stenotrophomonas maltophilia (SM), accounted for 1.58%. Logistic regression analysis showed that surgery, catheterization, mechanical ventilation, serious basic diseases and abuse of antibiotics were risk factors for MDRO infection in NSICU patients (P<0.05). \u0000 \u0000 \u0000Conclusions \u0000Invasive manipulation and antimicrobial abuse are the main risk factors for MDRO infection in NSICU patients, among which respiratory tract infection is the most serious and MRSA strain infection is the most common. The management of drugs and therapeutic devices should be scientific, rational and standardized in order to reduce the infection rate of MDRO. \u0000 \u0000 \u0000Key words: \u0000Intensive care units; Neurosurgery; Drug resistance, multiple, bacterial; Factor analysis, statistical","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74982264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent research on percutaneous endoscopic treatment of lumbar disc herniation in adolescents 经皮内镜治疗青少年腰椎间盘突出症的研究进展
Q4 Medicine Pub Date : 2019-12-20 DOI: 10.3760/CMA.J.ISSN.1008-1372.2019.12.046
Yanhu Liang, Long Yuan, Xuesong Li, Chunyang Meng
Lumbar disc herniation (LDH) is one of the most common degenerative spinal diseases in adults and less common in adolescents. The age of onset is less than 21 years old and is defined as adolescent lumbar disc herniation (ALDH). The incidence of ALDH is only 1%-5%. However, with the accelerated pace of life, the incidence of ALDH is increasing. In recent years, the rapid development of endoscopic technology has been widely used in spinal surgery. ALDH's percutaneous endoscopic technique has achieved good results. Compared with open surgery, percutaneous endoscopic treatment can preserve more normal lumbar structures, such as ligaments, muscles, lamina and facets, minimizing the impact on pubertal growth. This article reviews the characteristics of ALDH and endoscopic treatment as an entry point. Key words: Diskectomy, percutaneous; Endoscopy; Adolescent; Review
腰椎间盘突出症(LDH)是成人最常见的退行性脊柱疾病之一,在青少年中较少见。发病年龄小于21岁,定义为青少年腰椎间盘突出症(ALDH)。ALDH的发生率仅为1%-5%。然而,随着生活节奏的加快,ALDH的发病率也在增加。近年来,内窥镜技术发展迅速,在脊柱外科手术中得到广泛应用。ALDH的经皮内镜技术取得了良好的效果。与开放手术相比,经皮内镜治疗可以保留更多的正常腰椎结构,如韧带、肌肉、椎板和关节面,最大限度地减少对青春期生长的影响。本文回顾了ALDH的特点和内镜治疗为切入点。关键词:椎间盘切除术;经皮;内窥镜检查;青少年;审查
{"title":"Recent research on percutaneous endoscopic treatment of lumbar disc herniation in adolescents","authors":"Yanhu Liang, Long Yuan, Xuesong Li, Chunyang Meng","doi":"10.3760/CMA.J.ISSN.1008-1372.2019.12.046","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-1372.2019.12.046","url":null,"abstract":"Lumbar disc herniation (LDH) is one of the most common degenerative spinal diseases in adults and less common in adolescents. The age of onset is less than 21 years old and is defined as adolescent lumbar disc herniation (ALDH). The incidence of ALDH is only 1%-5%. However, with the accelerated pace of life, the incidence of ALDH is increasing. In recent years, the rapid development of endoscopic technology has been widely used in spinal surgery. ALDH's percutaneous endoscopic technique has achieved good results. Compared with open surgery, percutaneous endoscopic treatment can preserve more normal lumbar structures, such as ligaments, muscles, lamina and facets, minimizing the impact on pubertal growth. This article reviews the characteristics of ALDH and endoscopic treatment as an entry point. \u0000 \u0000 \u0000Key words: \u0000Diskectomy, percutaneous; Endoscopy; Adolescent; Review","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75427603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term effect of neuroendoscopy followed by radiotherapy on cystic craniopharyngiomas 神经内窥镜加放疗治疗囊性颅咽管瘤的远期疗效
Q4 Medicine Pub Date : 2019-12-20 DOI: 10.3760/CMA.J.ISSN.1008-1372.2019.12.006
Zhihui Wang, Xiaokun Geng
Objective To explore the long-term effect of neuroendoscopy followed by radiotherapy on cystic craniopharyngiomas. Methods Cystic craniopharyngiomas in 9 patients were treated with neuroendoscopic cyst aspiration and fenestration, followed by fractionated stereotactic radiotherapy (FSRT). The neuroendoscopic procedure focused on widening of cyst fenestration and extensive irrigation of the cyst contents. The collimator of FSRT ranged from 2.5 cm to 3.0 cm, and the target volume 1.1-43.8 cm3, dose per fraction 1.8 Gy, total dose 50.4 Gy. Results The median follow-up period was 72.9 months. Tumor control was achieved in 8 of 9 patients. Marked tumor volume reduction was obtained with the neuroendoscopic procedure alone at 6 months, 1 year, and 2 years. One recurrent case showed multilobulated cysts, and a second surgery was required 1 year after the treatment. Clinical symptoms such as headache and visual disruption were rapidly alleviated after the neuroendoscopic procedure. No new visual disturbances, endocrinopathy, or hypothalamic dysfunction was observed during follow up. Conclusions Stereotactic radiotherapy for cystic craniopharyngioma after endoscopic fenestration can effectively control the tumor for a long period of time, improve the clinical symptoms and avoid endocrine diseases. Key words: Craniopharyngioma; Neuroendoscopy; Stereotaxic techniques; Radiotherapy
目的探讨神经内镜联合放疗治疗囊性颅咽管瘤的远期疗效。方法对9例囊性颅咽管瘤患者行神经内窥镜囊肿抽吸开窗治疗,并行分割立体定向放疗(FSRT)。神经内窥镜手术的重点是扩大囊肿开窗和广泛冲洗囊肿内容物。FSRT准直器范围为2.5 ~ 3.0 cm,靶体积1.1 ~ 43.8 cm3,每分数剂量1.8 Gy,总剂量50.4 Gy。结果中位随访时间为72.9个月。9例患者中8例肿瘤得到控制。在6个月、1年和2年,单独使用神经内窥镜手术可以获得明显的肿瘤体积缩小。一个复发病例显示多分叶囊肿,治疗1年后需要第二次手术。临床症状,如头痛和视力障碍迅速缓解后,神经内窥镜手术。随访期间未发现新的视觉障碍、内分泌病变或下丘脑功能障碍。结论内镜开窗后立体定向放疗治疗囊性颅咽管瘤可长期有效控制肿瘤,改善临床症状,避免内分泌疾病。关键词:颅咽管瘤;Neuroendoscopy;立体定位技术;放射治疗
{"title":"Long-term effect of neuroendoscopy followed by radiotherapy on cystic craniopharyngiomas","authors":"Zhihui Wang, Xiaokun Geng","doi":"10.3760/CMA.J.ISSN.1008-1372.2019.12.006","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-1372.2019.12.006","url":null,"abstract":"Objective \u0000To explore the long-term effect of neuroendoscopy followed by radiotherapy on cystic craniopharyngiomas. \u0000 \u0000 \u0000Methods \u0000Cystic craniopharyngiomas in 9 patients were treated with neuroendoscopic cyst aspiration and fenestration, followed by fractionated stereotactic radiotherapy (FSRT). The neuroendoscopic procedure focused on widening of cyst fenestration and extensive irrigation of the cyst contents. The collimator of FSRT ranged from 2.5 cm to 3.0 cm, and the target volume 1.1-43.8 cm3, dose per fraction 1.8 Gy, total dose 50.4 Gy. \u0000 \u0000 \u0000Results \u0000The median follow-up period was 72.9 months. Tumor control was achieved in 8 of 9 patients. Marked tumor volume reduction was obtained with the neuroendoscopic procedure alone at 6 months, 1 year, and 2 years. One recurrent case showed multilobulated cysts, and a second surgery was required 1 year after the treatment. Clinical symptoms such as headache and visual disruption were rapidly alleviated after the neuroendoscopic procedure. No new visual disturbances, endocrinopathy, or hypothalamic dysfunction was observed during follow up. \u0000 \u0000 \u0000Conclusions \u0000Stereotactic radiotherapy for cystic craniopharyngioma after endoscopic fenestration can effectively control the tumor for a long period of time, improve the clinical symptoms and avoid endocrine diseases. \u0000 \u0000 \u0000Key words: \u0000Craniopharyngioma; Neuroendoscopy; Stereotaxic techniques; Radiotherapy","PeriodicalId":15276,"journal":{"name":"中国医师杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90312925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中国医师杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1